Biotech Losers: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Novavax, Inc. (NASDAQ:NVAX), Biogen Idec Inc (NASDAQ:BIIB)

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) and AstraZeneca (NYSE:AZN) are among those companies with late stage drugs in trials that specifically target genetic mutations. Both BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)’s BMN-673, which is in phase 3 trials, and Astra’s Olaparib, which may get the EU’s go-ahead in ovarian cancer this year, address a mutation of the BRCA 1 and BRCA 2 gene that is often associated with breast … Continue reading Biotech Losers: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Novavax, Inc. (NASDAQ:NVAX), Biogen Idec Inc (NASDAQ:BIIB)

Jayne Crisman03/2403/24

Biotech Bearish Stocks: Questcor Pharmaceuticals (NASDAQ:QCOR), ACADIA Pharmaceuticals (NASDAQ:ACAD), Idera Pharmaceuticals (NASDAQ:IDRA), Celldex Therapeutics (NASDAQ:CLDX)

Citron exposes explosive findings behind the true components of Questcor Pharmaceuticals Inc (NASDAQ:QCOR) flagship drug HP Acthar Gel. Questcor Pharmaceuticals Inc. (NASDAQ:QCOR) stock performance was -9.96% in last session and finished the day at $60.75. Traded volume was 0.00 shares in the last session and the average volume of the stock remained 2.86 million shares. The beta of the stock remained 0.95. Questcor Pharmaceuticals Inc. … Continue reading Biotech Bearish Stocks: Questcor Pharmaceuticals (NASDAQ:QCOR), ACADIA Pharmaceuticals (NASDAQ:ACAD), Idera Pharmaceuticals (NASDAQ:IDRA), Celldex Therapeutics (NASDAQ:CLDX)

John Bellich03/0303/03

Must Watch These 5 Stocks: Energy XXI (NASDAQ:EXXI), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Qihoo 360 Technology (NYSE:QIHU), Ford Motor Company (NYSE:F), Geeknet (NASDAQ:GKNT)

Energy XXI LTD (NASDAQ:EXXI) announced that James (Jim) LaChance and Norman (Norm) Louie have been named to its board of directors, increasing the size of the board to nine total, eight of whom are non-employee directors. The appointments were effective December 15, 2014 and both will stand for election by shareholders at the 2015 annual general meeting. Energy XXI Ltd (NASDAQ:EXXI) belongs to Basic Materials … Continue reading Must Watch These 5 Stocks: Energy XXI (NASDAQ:EXXI), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Qihoo 360 Technology (NYSE:QIHU), Ford Motor Company (NYSE:F), Geeknet (NASDAQ:GKNT)

Adam Keintzel12/1712/17

Top News : Arch Coal Inc. (NYSE:ACI), ArcelorMittal SA (ADR) (NYSE:MT), W. P. Carey Inc. (NYSE:WPC), Digital Power (NYSEMKT:DPW), Celldex Therapeutics (NASDAQ:CLDX)

Arch Coal Inc. (NYSE:ACI) is requesting that more than 300 acres of agricultural land be reclassified in order to expand an existing coal-waste storage facility. The board would have to approve the zoning board’s decision. Arch Coal Inc. (NYSE:ACI) belongs to Basic Materials sector. Its net profit margin is -24.30% and weekly performance is -23.58%. On last trading day company shares ended up $1.62. Arch … Continue reading Top News : Arch Coal Inc. (NYSE:ACI), ArcelorMittal SA (ADR) (NYSE:MT), W. P. Carey Inc. (NYSE:WPC), Digital Power (NYSEMKT:DPW), Celldex Therapeutics (NASDAQ:CLDX)

Jayne Crisman10/0810/08

Bluebirdbio BLUE NASDAQ BLUE

BioTech, Finance

Healthcare Gainers: Gentiva Health Services (NASDAQ:GTIV), bluebird bio Inc (NASDAQ:BLUE), Celldex Therapeutics (NASDAQ:CLDX), Intercept Pharmaceuticals (NASDAQ:ICPT), Northwest Biotherapeutics (NASDAQ:NWBO)

Gentiva Health Services Inc. (NASDAQ:GTIV)’s rejection of the takeover proposal from Kindred Healthcare Inc. ( KND ) is hitting headlines and drawing investor attention to the healthcare space. Gentiva Health Services, Inc. (NASDAQ:GTIV) stock performance was -1.52% in last session and finished the day at $13.62. Traded volume was 1.47million shares in the last session and the average volume of the stock remained 471.48K shares. … Continue reading Healthcare Gainers: Gentiva Health Services (NASDAQ:GTIV), bluebird bio Inc (NASDAQ:BLUE), Celldex Therapeutics (NASDAQ:CLDX), Intercept Pharmaceuticals (NASDAQ:ICPT), Northwest Biotherapeutics (NASDAQ:NWBO)

Mark DeFrance05/1905/19

Biotech Gainers: MannKind Corporation (NASDAQ:MNKD), Celldex Therapeutics (NASDAQ:CLDX), Dendreon Corporation (NASDAQ:DNDN), Intrexon Corp (NYSE:XON)

MannKind Corp. (NASDAQ: MNKD) was raised to Neutral from Underweight by Piper Jaffray. MannKind Corporation (NASDAQ:MNKD) stock performance was 6.53% in last session and finished the day at $7.01. Traded volume was 16.68million shares in the last session and the average volume of the stock remained 10.11million shares. The beta of the stock remained 1.40. MannKind Corporation (NASDAQ:MNKD) insider ownership is 0.30%. Celldex Therapeutics, Inc. … Continue reading Biotech Gainers: MannKind Corporation (NASDAQ:MNKD), Celldex Therapeutics (NASDAQ:CLDX), Dendreon Corporation (NASDAQ:DNDN), Intrexon Corp (NYSE:XON)

Mark DeFrance05/1505/15